Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82101-82150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05573841
Transfusion for Major Haemorrhage in Trauma - Characteristics and Outcomes
N/ARecruiting
300 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT04664179
EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
PHASE1Recruiting
44 participants
Started: Oct 31, 2022 · Completed: Mar 30, 2039
3 conditions3 sponsors2 locations
NCT05530239
Nano-rheological Biomarkers for Patients With Sickle Cell Disease (SCD) Versus Control Subjects (Other Constitutional Red Blood Cell Diseases and Healthy Subjects)
N/ANot yet recruiting
40 participants
Started: Oct 31, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor0 locations
NCT05588297
Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases
PHASE2Not yet recruiting
12 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor0 locations
NCT05420701
Surgical vs Percutaneous LAAO
NANot yet recruiting
260 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06595186
JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
PHASE2Recruiting
25 participants
Started: Oct 31, 2022 · Completed: Dec 16, 2026
1 condition1 sponsor1 location
NCT02978677
Proton Dose Escalation for Patients With Atypical or Anaplastic Meningiomas
NANot yet recruiting
90 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2029
1 condition3 sponsors0 locations
NCT05391490
Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies
PHASE1Not yet recruiting
12 participants
Started: Oct 31, 2022 · Completed: Nov 30, 2034
1 condition1 sponsor0 locations
NCT05478382
Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects
PHASE4Not yet recruiting
132 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
4 conditions2 sponsors0 locations
NCT05588583
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
NARecruiting
68 participants
Started: Oct 31, 2022 · Completed: Mar 31, 2024
6 conditions1 sponsor4 locations
NCT05594381
A Biomarker Study for Predicting the Efficacy of Neoadjuvant Sintilimab Plus SOX for Gastric Adenocarcinoma.
PHASE2Not yet recruiting
90 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
1 condition3 sponsors0 locations
NCT05591261
Strong Couples Project: Disseminating Evidence-based Relationship Education
NANot yet recruiting
500 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2027
2 conditions1 sponsor1 location
NCT05556031
Ambulatory Heart Failure Service Model Study
N/ANot yet recruiting
500 participants
Started: Oct 31, 2022 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05585320
A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
PHASE1/PHASE2Active, not recruiting
209 participants
Started: Oct 31, 2022 · Completed: Jun 30, 2027
4 conditions1 sponsor20 locations
NCT06076889
Power Over Pain Portal: A Stepped-care Virtual Solution to Deliver Early Intervention to Canadian Youth With Chronic Pain
N/ARecruiting
100 participants
Started: Oct 31, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05557201
Cohort of Patients Presenting Unexplained Recurrent Miscarriages and Identification of Early Miscarriage Recidivism Factors
N/ANot yet recruiting
500 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05567588
Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer
PHASE2Recruiting
66 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
1 condition1 sponsor2 locations
NCT05098444
Efficacy of Internet-based Cognitive Behavioral Therapy for Endometriosis
NAActive, not recruiting
120 participants
Started: Oct 31, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05534698
Coronary Artery Bypass Grafts or Percutaneous Coronary Intervention for High Risk Patients
NANot yet recruiting
1,550 participants
Started: Oct 31, 2022 · Completed: Feb 28, 2033
2 conditions1 sponsor1 location
NCT05520476
Neuroliten MVP System Clinical Observation Study
N/AActive, not recruiting
20 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05430139
Dried Blood Spot Testing for At Home Health
N/ARecruiting
2,000 participants
Started: Oct 31, 2022 · Completed: Mar 31, 2025
2 conditions1 sponsor1 location
NCT05582187
A Clinical Trial of the Study Medicine (Called Fosmanogepix) in Participants With Varying Degrees of Hepatic Function.
PHASE1Recruiting
30 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT05568238
Vacuum Assisted Wound Closure and Permanent On-lay Mesh-mediated Fascial Traction in Patients With Open Abdomen
NANot yet recruiting
100 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor0 locations
NCT06013748
Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial
NARecruiting
112 participants
Started: Oct 31, 2022 · Completed: Feb 1, 2026
1 condition2 sponsors3 locations
NCT05133882
A Phase Ⅰb/Ⅱ Clinical Study of Clifutinib Besylate Combined With Chemotherapy in the Treatment of Newly Diagnosed AML
PHASE1/PHASE2Recruiting
133 participants
Started: Oct 31, 2022 · Completed: Aug 15, 2026
1 condition1 sponsor1 location
NCT05565183
Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation.
NANot yet recruiting
60 participants
Started: Oct 31, 2022 · Completed: Nov 30, 2025
4 conditions1 sponsor1 location
NCT05407168
Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
NARecruiting
300 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2027
1 condition3 sponsors4 locations
NCT05564988
Chronic Remote Ischemic Preconditioning as a Complement to Conventional Prenatal Care for Preeclampsia
NANot yet recruiting
58 participants
Started: Oct 31, 2022 · Completed: Feb 28, 2026
1 condition1 sponsor0 locations
NCT05593822
The Relationship Between Myocardial Blush Grade and T-P-e Interval and QRS Width: Impact on In-Hospital Outcome After Successful Primary Percutaneous Coronary Intervention
NANot yet recruiting
80 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05584020
Arthroscopic Anterior Cruciate Ligament Repair Versus Reconstruction for Acute Anterior Cruciate Ligament Injury
NARecruiting
330 participants
Started: Oct 31, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05454163
Post-radiotherapy Rhinosinusitis in Children
N/ANot yet recruiting
55 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2025
2 conditions2 sponsors0 locations
NCT04283513
Treatment of Hemorrhagic Fever With Ribavirin
PHASE2Active, not recruiting
50 participants
Started: Oct 31, 2022 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT05327452
Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study
NARecruiting
135 participants
Started: Oct 31, 2022 · Completed: May 31, 2026
3 conditions3 sponsors2 locations
NCT05564871
Effectiveness of Occupational Therapy Teleintervention in Pediatric
NANot yet recruiting
40 participants
Started: Oct 31, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor0 locations
NCT05556499
The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism
N/ANot yet recruiting
100 participants
Started: Oct 31, 2022 · Completed: Jun 24, 2026
3 conditions1 sponsor1 location
NCT05510830
Diagnostic Cervical Conization for Persistent Infection or Integration of HPV
NANot yet recruiting
250 participants
Started: Oct 31, 2022 · Completed: Jan 31, 2030
5 conditions2 sponsors1 location
NCT06560242
Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG- Infant
NARecruiting
30 participants
Started: Oct 31, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT07045571
MSCAN: ctDNA Methylation as Prognostic and Theranostic Tool for Pancreatic Cancer
N/ARecruiting
1,000 participants
Started: Oct 30, 2022 · Completed: Jul 22, 2026
2 conditions4 sponsors1 location
NCT05582109
Envafolimab, Lenvatinib Combined With TACE in the Treatment of Unresectable Locally Advanced Hepatocellular Carcinoma
PHASE2Not yet recruiting
30 participants
Started: Oct 30, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor0 locations
NCT05600803
Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
N/ARecruiting
236 participants
Started: Oct 30, 2022 · Completed: Oct 30, 2025
2 conditions1 sponsor1 location
NCT05607745
Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study
NAActive, not recruiting
54 participants
Started: Oct 30, 2022 · Completed: Dec 31, 2026
9 conditions6 sponsors3 locations
NCT05568498
Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease
PHASE2Not yet recruiting
60 participants
Started: Oct 30, 2022 · Completed: Oct 30, 2026
2 conditions1 sponsor0 locations
NCT06291129
Gingival Health and Malocclusion Among Type 1 Diabetic Children and Adolescents
NAActive, not recruiting
36 participants
Started: Oct 30, 2022 · Completed: Oct 30, 2024
6 conditions1 sponsor1 location
NCT04095676
VATS Surgery Compared to Drainage in the Treatment of Pleural Empyema
NARecruiting
184 participants
Started: Oct 30, 2022 · Completed: Oct 30, 2028
1 condition4 sponsors3 locations
NCT05579184
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2
PHASE2Active, not recruiting
20 participants
Started: Oct 30, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05443633
Enhancing Language Function in Aphasia
NARecruiting
30 participants
Started: Oct 30, 2022 · Completed: Dec 15, 2028
4 conditions1 sponsor1 location
NCT05596097
Zanubrutinib in Maintenance Therapy of DLBCL Patients With Initial Remission
PHASE2Not yet recruiting
15 participants
Started: Oct 30, 2022 · Completed: Jul 30, 2026
1 condition2 sponsors1 location
NCT06529653
Ridge Splitting Using Autogenous Bone Wedge Versus the Conventional Intercortical Augmentation Technique in Horizontally Deficient Anterior Maxilla
NARecruiting
20 participants
Started: Oct 30, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05423587
Genicular Artery Embolisation for Knee Osteoarthritis II
NARecruiting
110 participants
Started: Oct 30, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor1 location
NCT05609318
Imaging Intravenous Iron
N/ARecruiting
12 participants
Started: Oct 29, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location